基因治疗中的免疫调节策略:克服免疫障碍并提高效率
Sivaprakasam S Amsaveni1, Radha Mahendran1, Vidhya C S2
1Department of Bioinformatics, School of Life Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram-600117, Chennai, Tamilnadu, India.
Current gene therapy
|October 3, 2024
概括
基因疗法面临着免疫系统的挑战. 本研究审查了免疫调节策略,包括检查点调节和新型载体,以提高基因治疗的安全性和有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 基因治疗 基因治疗
- 生物技术是生物技术.
背景情况:
- 免疫系统对基因疗法的有效性提出了重大挑战.
- 目前的基因治疗方法受到不良免疫反应的限制.
研究的目的:
- 探索新的免疫调节技术,以优化基因疗法.
- 解决障碍并指导免疫介导基因疗法的未来发展.
主要方法:
- 审查免疫控制策略,包括免疫检查点和免疫调节药物.
- 调查设计较少免疫性基因传递载体的进展.
- 分析向基因传递和扩展转基因表达的分析方法.
主要成果:
- 新的方法可以在基因治疗期间加强对免疫反应的控制.
- 开发出较少免疫性载体可以最大限度地减少不良免疫反应.
- 免疫耐受性和有针对性的治疗策略可以改善治疗结果.
结论:
- 整合免疫调节技术提供了更安全,更有效的基因疗法.
- 克服与免疫相关的障碍是推动基因治疗应用的关键.
- 微调免疫反应对于最大限度地发挥基因治疗潜力至关重要.
相关概念视频
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
Cell-mediated Immune Responses
67.7K
Overview
67.7K
Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857


